EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ensemble learning approach with explainable AI for improved heart disease prediction

Ayomide Adekoya, Faisal Saeed, Wad Ghaban, Sultan Noman Qasem

Frontiers in Pharmacology · 11.12.2025 · 16

DOI: 10.3389/fphar.2025.1654681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 11.12.2025. Verfasst von Ayomide Adekoya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science, Birmingham City University, Birmingham, United Kingdom. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Imam Mohammed Ibn Saud Islamic University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Heart disease remains a leading cause of global morbidity and mortality, motivating the development of predictive models that are both accurate and clinically interpretable. We introduce the Interpretable Ensemble Learning Framework (IELF), which integrates Explainable Boosting Machines (EBM) with XGBoost, SHAP-based explanations, and LIME for enhanced local interpretability.

Methods

IELF was evaluated on two benchmark datasets: Cleveland (n = 303) and Framingham (n = 4,240). Model assessment included 5-fold cross-validation, held-out test sets, calibration, subgroup analyses, and explanation stability evaluation using Kendall’s τ and Overlap@10.

Results

IELF achieved robust discrimination (AUC 0.899, accuracy 88.5% on Cleveland; AUC 0.696, accuracy 82.6% on Framingham) with balanced precision–recall profiles. Compared with EBM, IELF significantly improved recall, F1, and AUC on the Framingham dataset (p < 0.05), while differences versus XGBoost were less consistent. IELF produced transparent feature rankings aligned with established cardiovascular risk factors and stable explanations across folds.

Discussion

IELF is, to our knowledge, the first framework to combine EBM and XGBoost with SHAP and LIME under strict nested cross-validation and calibration procedures. Although headline accuracies are lower than some recent >97% reports, IELF was developed under stricter methodological controls that enhance reproducibility, interpretability, and clinical reliability. These findings position IELF as a trustworthy benchmark for translational AI in cardiovascular risk prediction, complementing high-accuracy but less transparent models.

Schlagwörter

Stichwörter der Autor:innen

XGBoostcardiovascular diseaseensembleensemble learningexplainable AIheart disease

Autor:innen und Institutionen

  • Department of Computer Science, Birmingham City University, Birmingham, United Kingdom.
  • Applied College, University of Tabuk, Tabuk, Saudi Arabia.
  • Computer Science Department, College of Computer and Information Sciences, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.

Förderung

  • Imam Mohammed Ibn Saud Islamic University

Zitieren

APA

Adekoya, A., Saeed, F., Ghaban, W., & Qasem, S. N. (2025). Ensemble learning approach with explainable AI for improved heart disease prediction. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1654681

Vancouver

Adekoya A, Saeed F, Ghaban W, Qasem SN. Ensemble learning approach with explainable AI for improved heart disease prediction. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1654681

BibTeX
@article{Adekoya2025,
  author = {Adekoya, Ayomide and Saeed, Faisal and Ghaban, Wad and Qasem, Sultan Noman},
  title = {Ensemble learning approach with explainable AI for improved heart disease prediction},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1654681}
}
Kostenlos starten →